A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

Clinical trial NCT02363491 · COMPLETED

Trial details

NCT number: NCT02363491
Sponsor: Opsona Therapeutics Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2015-01-01
Primary completion: 2018-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.